background: There is evidence that intrauterine growth restriction, resulting in newborn girls that are small for gestational age (SGA), may be related to the onset of polycystic ovary syndrome (PCOS). Thus, we studied whether women born SGA have a higher prevalence of PCOS than women born appropriate for gestational age (AGA).
Introduction
Polycystic ovary syndrome (PCOS) is a heterogeneous and complex endocrine disorder with an estimated prevalence of 5 -10% of women of reproductive age (Belosi et al., 2006) and this syndrome represents the main cause of hyperandrogenism and chronic anovulation (Norman et al., 2007) . It is commonly associated with metabolic disorders, at times preceding the onset of diseases such as type 2 diabetes mellitus (Moran et al., 2010) and hypertension in the fourth decade of life (Elting et al., 2001) . Its aetiology is still poorly understood, but the interaction of genetic and environmental factors appears to play a fundamental role in its onset (Franks et al., 2006) . Over the last few years, experimental studies have indicated fetal reprogramming by prenatal androgen excess as a possible aetiology of PCOS (Abbott et al., 2005) , but the relevance of these studies to the developmental origin of human PCOS remains questionable (Hickey et al., 2009) .
Fetal reprogramming is defined by changes in gene expression without alterations in the DNA sequence (epigenetic modification) (Li and Huang, 2008) . This phenomenon may be the consequence of intrauterine growth restriction (IUGR), a condition involving the elevation of glucocorticoid levels as a defence mechanism of the fetus to guarantee its intrauterine survival in situations of hypoxia. IUGR may cause the birth of small for gestational age (SGA) newborns with weights below the 10th percentile for their gestational age (Fowden and Forhead, 2004) . SGA girls tend to become hyperinsulinaemic and to present central adiposity from childhood onwards (Ibáñez et al., 2006 (Ibáñez et al., , 2009 , and they tend to have a reduced ovulation rate in adolescence (Ibáñez et al., 2002) . During their adult lives, they are at a higher risk for developing metabolic syndrome (Jaquet et al., 2005) , hypertension and type 2 diabetes mellitus (Tian et al., 2006) .
Although the hypothesis of a developmental origin of PCOS has great plausibility, the level of evidence of the association of PCOS and birthweight in relation to gestation age remains questionable in clinical studies. The first problem is the inclusion of preterm newborns (Cresswell et al., 1997; Laitinen et al., 2003; Pandolfi et al., 2008) , since the functional maturation of the organs and tissues of preterm newborns may be completed during post-natal life and therefore be influenced by the extrauterine environment (Ben, 2008) . The second problem is that some studies have not evaluated all possible PCOS phenotypes and the prevalence of this syndrome, but have evaluated symptoms like clinical hyperandrogenism or menstrual irregularity alone (Laitinen et al., 2003) , a fact that can lead to exclusion of some PCOS phenotypes and a possible underestimate of the real prevalence of PCOS.
Thus, the main objective of the present study was to determine whether women-born SGA have a higher prevalence of PCOS than women born appropriate for gestational age (AGA) in a sample from the 1978/79 birth cohort of Ribeirão Preto, Brazil.
Methods

Subjects
This was a prospective study of a birth cohort. The study population consisted of a sample of 384 women born at term in the city of Ribeirão Preto, state of São Paulo, Brazil, from June 1, 1978 to May 31, 1979 . These patients have been followed up since birth at the Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP-USP) and were assessed at two different times: 1985 -1987 and 2002-2004. Included in the study were women of reproductive age from the above cohort born at term (37-42 weeks) whose follow-up data had been updated in 2002 -2004 . The participants were divided into two groups based on birthweight in relation to gestational age: (i) SGA newborns with birthweight below the 10th percentile and (ii) AGA newborns with birthweight between the 10th percentile and the 90th percentile (Battaglia and Lubchenco, 1967) . The study was approved by the Institutional Review Board of the Hospital of FMRP-USP, and all women gave written informed consent to participate.
The cohort included 3095 singleton females born at term. Of these, 1064 were recruited in 2002 -2004 (one-third of the 1978 -1979 sample) , and 1002 of them were term newborns [(101 SGA, 849 AGA and 52 large for gestational age (LGA)] (Barbieri et al., 2006) . Because LGA women (birthweight above the 90th percentile for gestational age) were not considered in the present study, 950 subjects fulfilled the inclusion criteria for the 2007 -2008 follow-up. To demonstrate an absolute difference of 15% in the prevalence of PCOS between SGA and AGA women, 99 subjects per group would be necessary (a total of 198 women), considering an a of 5% and a power of 80%. Thus, between November 2007 and October 2008, all women who were SGA newborns (101) and a random subsample of 283 AGA women (one in every three women) were recruited by a computer program (www.randomizer.org), for a total of 384 subjects. Of these, 21 did not accept the invitation to participate in the study and 48 were not located after five search attempts (i.e. telephone contact, updating of telephone number according to the address of the files of the cohort follow-up, correspondence, convocation through the press, radio and television and an active search based on the municipal health registry). In addition, some women were excluded according to the following criteria: users of a hormonal contraceptive who did not wish to do a wash-out of at least 12 weeks even when a non-hormonal contraceptive was offered as an alternative (N ¼ 76), pregnant women (N ¼ 63) and nursing women (N ¼ 11). After exclusion, 165 women effectively participated in this study, of which 43 were SGA and 122 AGA. A flow chart of the study is illustrated in Fig. 1 .
Protocols of clinical and laboratory evaluation
Patients were evaluated at the Laboratory of Gynaecology of FMRP-USP during a single visit after a 12-h fast, between the third and fifth day of their menstrual cycle. In the presence of amenorrhoea, the examination was performed on any day of the menstrual cycle as long as the presence of a corpus luteum or of a follicular image larger than 10 mm was ruled out by ultrasound (US).
All women underwent anamnesis and a physical examination by a single observer who was not aware of the neonatal data of the study group. They were questioned and examined for determination of the following characteristics: menstrual cycle [oligomenorrhoea (cycles at intervals .35 days), amenorrhoea (absence of menstrual flow for at least three consecutive cycles), regular cycles (intervals of 24 -32 + 3 days and duration of 3 -7 days)]; signs of clinical hyperandrogenism (acne, alopecia and hirsutism, defined by a modified Ferriman index ≥8) (Ferriman and Gallwey, 1961) ; habits [smoking and sedentarism (defined by a frequency of physical activity ,10 continuous min/week)] (Craig et al., 2003) ; weight; height; body mass index (BMI, defined as weight (kg)/height (m) 2 ; obesity was defined as BMI ≥30 kg/m 2 ) (World Health Organization, 1998); systolic blood pressure (SBP) and diastolic blood pressure (DBP) and acanthosis nigricans. Gestational age at delivery, age at menarche, birthweight data, race by self-report [white and non-white (Black, Asian, Indian and MixedMulatto)] and maternal data (age, parity, marital status, years of formal study and smoking habit) were obtained from the cohort files. In 1978/ 79, birthweight was measured at the hospital by qualified personnel and the scales were calibrated on a weekly basis. Gestational age was calculated to the nearest week from the first day of the last menstrual period. After a 15-min rest, 20 ml of venous blood was collected. Of this sample, 10 ml was centrifuged at 2500 rpm (1600 g) at room temperature for 10 min and stored at 2708C for later determination of hormones and steroid hormone-binding globulin (SHBG) in a single procedure. The remaining 10 ml was used for biochemical analysis within a maximum of 2 h after collection.
Follicle stimulating hormone (FSH), luteinizing hormone (LH), fasting insulin and SHBG levels were determined by chemiluminescence using a DPC Immulite w 2000 apparatus (Diagnostic Products Corporation, Los Angeles, CA, USA w ). Total testosterone, 17-OH progesterone and dehydroepiandrostenedione sulphate (DHEAS) were determined by radioimmunoassays using a Tri Carb 2100 TR scintillator (Packard w Instrument Company, IL, USA). Fasting glucose levels were determined by the oxidation method, using the Konelab 60i kit and a Wiener Lab w apparatus (Rosario, Argentina).
The intra-and inter-assay error coefficients for the hormonal parameters were 4.9 and 6.1% for FSH, 2.3 and 3.7% for LH, 3.3 and 4.1% for total testosterone, 2.1 and 2.8% for 17-OH progesterone, 1.5 and 2.1% for DHEAS, 6.1 and 6.5% for insulin and 5.3 and 6.1% for SHBG, respectively.
Before the clinical and laboratory evaluation, a single observer who was unaware of the neonatal data of the patients performed the US examination using an HDI 3000 apparatus (ATL US, Bothell, WA, USA) to determine the ovarian volume and the number and size of the follicles present. The ovarian volume was calculated by the prolate ellipsoid formula (depth × width × length × 0.5) (Griffin et al., 1995) , and the mean volume of the right and left ovaries of each patient was used to compare the SGA and AGA groups. When dominant follicles (more than 10 mm) or a corpus luteum were present, the patient was instructed to come to the hospital during the early follicular phase of the next cycle for a new US and new blood tests.
The free androgen index (FAI) was calculated by the following formula: total testosterone (mmol/l)/SHBG (mmol/l) × 100 (Mathur et al., 1981) . Insulin resistance (IR) was determined by the homeostasis model assessment-IR index (HOMA-IR), i.e. HOMA-IR ¼ fasting glucose (mg/dl) × 0.05551 × fasting insulin (mU/ml)/22.5 (Matthews et al., 1985) , and a diagnosis of IR was defined by the presence of HOMA-IR .2.71 (Geloneze et al., 2006) .
On the basis of the clinical, laboratory and US characteristics of the women in the study, the Rotterdam Consensus was used to diagnose and assess the prevalence of PCOS (The Rotterdam ESHRE/American Society of Reproductive Medicine (ASRM)-Sponsored PCOS Consensus Workshop Group, 2004) . All women with PCOS had normal thyroid function and prolactin levels. The prevalence of PCOS was also determined according to the criteria of the National Institutes of Health (NIH) (Zawadski and Dunaif, 1992) . Next, women with PCOS in the SGA and AGA groups were evaluated phenotypically as follows: (i) complete/ severe PCOS [menstrual irregularity (MI) + clinical and/or laboratory hyperandrogenism (HA) + US criterion]; (ii) MI + HA; (iii) mild PCOS (MI + US) and (iv) ovulatory PCOS (HA + US) (Norman et al., 2007) .
Statistical analyses
Quantitative variables were tested for normal distribution by the Kolmogorov-Smirnov, D'Agostino and Pearson tests. When the distribution was found to be normal, data were analysed by Student's t-test, and when the distribution was not normal, data were analysed by the Mann-Whitney test. The quantitative variables are reported as the mean + standard deviation (SD). Qualitative variables were analysed statistically by the Fisher and chi-squared tests, and the relative risk (RR) and 95% confidence interval (CI) were also calculated. The level of significance was set at 5%, and the statistical analyses were performed with the aid of SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA) and SAS 9.0 software (SAS Institute, Inc., Cary, NC, USA).
With the presence of PCOS considered as the response variable, univariate analysis of unadjusted RR was performed for any possible predictive variables (i.e. SGA, IR, sedentarism, BMI and maternal smoking, parity, marital status, schooling and age). Variables with P , 0.250 in the univariate analysis were considered in the multivariate model. The adjusted RR values of the SGA, IR, BMI, maternal smoking and parity variables were analysed using Poisson regression with robust adjustment of variance for the prediction of PCOS. This statistical analysis was 
Results
No significant difference in maternal characteristics was observed between the study groups (Table I) . Except for birthweight (SGA 2492 + 233.8 g versus AGA 3272.8 + 342.4 g, P ¼ 0.001) and current height (SGA 1.59 + 0.06 m versus AGA 1.63 + 0.06 m, P ¼ 0.001), the clinical variables were also similar in the AGA and SGA women (Table II) .
The prevalence of PCOS was more than double in the SGA group compared with the AGA group according to the Rotterdam criteria [SGA 30.2% versus AGA 13.9%, P ¼ 0.017), with an adjusted RR of 2.44 (95% CI: 1.39 -4.28)], and about double according to the NIH criteria [SGA 18.6% versus AGA 9.8%, P ¼ 0.172, and RR of 1.66 (95% CI ¼ 0.9 -3.05)]. Multivariate analysis showed that BMI and being born SGA were independent predictors for the development of PCOS (Table III) .
Regarding the diagnostic criteria of PCOS, menstrual irregularity was more frequent among the SGA women (SGA 48.8% versus AGA 25.4%, P ¼ 0.007). Similarly, clinical and/or laboratory hyperandrogenism (SGA 44.2% versus AGA 22.9%, P ¼ 0.011) were more frequent and the modified Ferriman index (SGA 5.5 + 1.8 versus AGA 4.2 + 1.7, P , 0.001) was higher in the SGA group. However, ovarian volume (SGA 8.3 + 4.4 cm 3 versus AGA 7.8 + 4.4 cm 3 , P ¼ 0.600) and the polycystic morphology of the ovaries (SGA 32.5% versus AGA 22.9%, P ¼ 0.227) did not differ significantly between the groups (Fig. 2) . Mean fasting glucose, mean hormone levels (FSH, LH, 17-OH progesterone, DHEAS, total testosterone, FAI and fasting insulin) and HOMA-IR were similar for the SGA and AGA groups, but SGA women had a lower concentration of SHBG than AGA women (SGA 53.9 + 22.9 nmol/l versus AGA 64 + 37.3 nmol/l, P ¼ 0.041) (Table IV) .
Regarding the phenotypic manifestations of PCOS, the complete/ severe form was the most prevalent in both groups, and there was no difference between SGA and AGA for all the phenotypes (P ¼ 0.999 for all comparisons) ( Table V) .
Discussion
The present study demonstrated that the risk of developing PCOS during the third decade of life was twice as high among SGA newborns compared with AGA newborns. This risk was maintained even when the RR was adjusted for BMI, IR, maternal parity and maternal smoking, demonstrating that birthweight in relation to gestational age is an independent predictor of PCOS in adult life. Although SGA newborns were at higher risk of developing PCOS in adult life, the phenotypic distribution was similar for the SGA and AGA groups, suggesting that birthweight below the 10th percentile for gestational age does not determine a preferential phenotype when compared with AGA women with PCOS.
The current cohort study represents the first quantification of the association between birthweight in relation to gestational age and the prevalence of PCOS among adult women born at term in the same place and during the same time period. This study design is important because it minimizes the influence of environmental factors on the evaluation, avoiding some selection biases that may occur in a convenience sample when individuals are recruited at The quantitative data are reported as the mean + SD. SGA, small for gestational age; AGA, appropriate for gestational age; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.
different times and places due to environmental heterogeneity. Previous studies that introduced the hypothesis of an association between birthweight and the development of PCOS had limitations because they included preterm newborns in the samples (Cresswell et al., 1997; Laitinen et al., 2003; Pandolfi et al., 2008) or had a retrospective design with a convenience sample (Pandolfi et al., 2008) without quantification of the risk for developing PCOS (Cresswell et al., 1997; Laitinen et al., 2003; Pandolfi et al., 2008 ). An important question regarding the evaluation of PCOS prevalence involves the criteria used for this purpose. Several societies use different standards to define PCOS, but the criteria established by the NIH (Zawadski and Dunaif, 1992) and by the Rotterdam Consensus are those most frequently used in clinical practice. In the present study, we used the Rotterdam Consensus, which is used as the diagnostic protocol in PCOS of our service and is also the diagnostic standard recommended by the ASRM** and the European Society of Human Reproduction and Embryology (ESHRE) (The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004) . However, even when we used the NIH criteria (Zawadski and Dunaif, 1992) , the prevalence of PCOS in the SGA group was approximately double the prevalence in the AGA group. According to Broekmans et al. (2006) and Norman et al. (2007) , the prevalence of PCOS based on the NIH criteria can be one to five times lower than that obtained by the Rotterdam Consensus because the inclusion of the US criterion for the diagnosis of PCOS increases diagnostic sensitivity. Because PCOS represents a set of signs and symptoms, several authors have studied the relationship between birthweight and the criteria for the definition of PCOS. In the present study, menstrual irregularity was found to be more frequent among women born SGA. In contrast, Laitinen et al. (2003) demonstrated that the presence of menstrual irregularity and hirsutism (defined by the complaint of the patient without any objective score) was associated with obesity but not with birthweight, although the other signs of hyperandrogenism (i.e. acne and alopecia), the US criterion and, consequently, the prevalence of PCOS were not evaluated by these authors. Furthermore, these authors did not exclude other causes of hyperandrogenism that could be responsible for hirsutism.
Regarding the ultrasonographic criterion for the definition of PCOS, the present study did not detect a significant difference in the frequency of this finding between the SGA and AGA groups. Ibáñez et al. (2008) studied the frequency of polycystic ovary using US in 86 hyperandrogenic, non-obese adolescents and found that lower birthweight was less associated with polycystic ovaries. Similarly, Cresswell et al. (1997) also observed that the ultrasonographic morphology of polycystic ovaries was related to having been born with higher weight in a series of 235 perimenopausal women from a birth cohort in the United Kingdom. It is important to point out that studies conducted before The Rotterdam ESHRE/ASRMSponsored PCOS Consensus Workshop Group (2004) may present differences in the criteria for the definition of polycystic by US.
Hyperandrogenism was twice as frequent in women of the SGA group compared with women of the AGA group, despite the absence of differences in serum levels of total and free testosterone between the groups. Similarly, Ibáñez et al. (2003) did not find differences in androgen levels between SGA and AGA women in a series of 28 women evaluated at 14 and 18 years of age. On the other hand, when the same authors analysed 49 adolescents in another study, they detected a higher androgen concentration in the SGA group (Ibáñez et al., 2002) . Thus, the determination of total and free testosterone has limitations that may be explained by two major characteristics: (i) laboratory kits have high failure rates (approximately 20 -40%) in adequately determining the serum concentrations of these sex steroids (Chang et al., 2005; Norman et al., 2007) and (ii) most of these assays are not standardized according to sex or age range (Vermeulen et al., 1999) .
Due to the higher prevalence of PCOS among SGA newborns, hyperinsulinaemia and IR may be present in this group. However, the insulin level and IR did not differ between the groups studied here, suggesting that the sequence of events associated with fetal reprogramming (hyperinsulinaemia-hyperandrogenism-PCOS) may not universally occur in all newborns who had IUGR. A possible hypothesis for this result is based on experimental studies demonstrating that the relationship between insulin levels and hyperandrogenism in the SGA women may depend on the phase of pregnancy during which the hypoxic insult or prenatal androgen excess happens. When these events occur during advanced phases of pregnancy, changes in the reproductive axis (hyperandrogenism) predominate, with no repercussions on glucose metabolism. Conversely, when epigenetic changes occur during early gestation, alterations related to both glucose metabolism and the reproductive axis (hyperinsulinaemia with hyperandrogenism) also occur (Abbott et al., 2005) .
It is important to point out that the determination of insulin levels by the fasting levels (or by scores such as HOMA-IR, which also use fasting insulin and fasting glucose values) may be a source of bias in the determination of IR. In fact, SHBG levels were lower in the SGA women than in the AGA women, indicating that SGA women may have a subtle degree of IR (Pasquali et al., 1995; Haffner, 1996) that was not readily detected with fasting insulinaemia and glycaemia. Although the glycaemic clamp is the gold standard method for evaluation of IR, this method is not feasible for cohort studies. Therefore, the HOMA-IR would be a more viable alternative because it has a good correlation with the clamp (Radikova, 2003) .
Although more than 80% of the women included in the present study accepted participation in the proposed evaluation, part of the sample was excluded. This occurred because 70% of Brazilian pregnancies occur in this age range, and many women did not wish to discontinue their use of hormonal contraceptives (even when non-hormonal methods were offered), which is the method most frequently used in Brazil (Oliveira and Nunes, 2009 exclusion criterion for the study due to the interference of hormonal contraceptives with the determination of hormonal levels and the diagnosis of PCOS. The absence of the assessment of insulin levels during infancy in the groups studied, as well as the absence of maternal data about the prevalence of PCOS, may also represent limitations of this study. However, standardization of the diagnosis of PCOS was only performed in the last decade (Zawadski and Dunaif, 1992 ; The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004) .
In conclusion, the prevalence of PCOS in the SGA women was twice as high as in the AGA women in our study population. Cohort studies involving the evaluation of birth, adolescence and adult life data, as well as genetic studies, are essential for more accurate conclusions about the possible sequences of events linked to fetal reprogramming that would lead to the development of PCOS.
